* Vivani Medical Inc is expected to report resultson March 25 (estimated) for the period ending December 31 2023
*
* LSEG's mean analyst estimate for Vivani Medical Inc is for a loss of 14 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Vivani Medical Inc is $8.00, above its last closing price of $2.03.
This summary was machine generated March 22 at 20:55 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments